Related references
Note: Only part of the references are listed.Diagnosing Cervical Cancer and High-Grade Precursors by HPV16 Transcription Patterns
Markus Schmitt et al.
CANCER RESEARCH (2010)
Activities of E7 promoters in the human papillomavirus type 16 genome during cell differentiation
Christina Neigaard Hansen et al.
VIRUS RESEARCH (2010)
The SR protein family of splicing factors: master regulators of gene expression
Jennifer C. Long et al.
BIOCHEMICAL JOURNAL (2009)
The regulation of cell proliferation by the papillomavirus early proteins
N. Abdul Hamid et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Connecting viral with cellular interactomes
S. M. Bailer et al.
CURRENT OPINION IN MICROBIOLOGY (2009)
RNAi-based therapeutics-current status, challenges and prospects
Katrin Tiemann et al.
EMBO MOLECULAR MEDICINE (2009)
Topical treatment of CIN 2+by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study
C. Van Pachterbeke et al.
GYNECOLOGIC ONCOLOGY (2009)
Increased Expression of Cellular RNA-Binding Proteins in HPV-Induced Neoplasia and Cervical Cancer
Joanna Fay et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
RNA splicing factors regulated by HPV16 during cervical tumour progression
Sarah Mole et al.
JOURNAL OF PATHOLOGY (2009)
Human Papillomavirus Type 16 E2 Protein Transcriptionally Activates the Promoter of a Key Cellular Splicing Factor, SF2/ASF
Sarah Mole et al.
JOURNAL OF VIROLOGY (2009)
The Human Papillomavirus (HPV) E6*Proteins from High-Risk, Mucosal HPVs Can Direct Degradation of Cellular Proteins in the Absence of Full-Length E6 Protein
David Pim et al.
JOURNAL OF VIROLOGY (2009)
Protection against Retrovirus Pathogenesis by SR Protein Inhibitors
Anne Keriel et al.
PLOS ONE (2009)
The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells
S. A. Cumming et al.
VIROLOGY (2009)
Transcriptional regulation of the papillomavirus oncogenes by cellular and viral transcription factors in cervical carcinoma
Francoise Thierry
VIROLOGY (2009)
Papillomaviruses in the causation of human cancers - a brief historical account
Harald zur Hausen
VIROLOGY (2009)
Inhibition of transcription and DNA replication by the papillomavirus E8ΛE2C protein is mediated by interaction with corepressor molecules
Ingo Ammermann et al.
JOURNAL OF VIROLOGY (2008)
The E8∧E2 Gene Product of Human Papillomavirus Type 16 Represses Early Transcription and Replication but Is Dispensable for Viral Plasmid Persistence in Keratinocytes
Michael J. Lace et al.
JOURNAL OF VIROLOGY (2008)
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Zefeng Wang et al.
RNA (2008)
Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding
Tonia R. Wooldridge et al.
VIROLOGY (2008)
The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element
Thanaporn Cheunim et al.
VIRUS RESEARCH (2008)
Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers
Xiaomin Zhao et al.
VIROLOGY (2007)
Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance
Nadia Bakkour et al.
PLOS PATHOGENS (2007)
Human papillomavirus type 31 uses a caveolin 1-and dynamin 2-mediated entry pathway for infection of human keratinocytes
Jessica L. Smith et al.
JOURNAL OF VIROLOGY (2007)
Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR
Nicole-Claudia Meisner et al.
NATURE CHEMICAL BIOLOGY (2007)
Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation
Wenyi Gu et al.
NUCLEIC ACIDS RESEARCH (2007)
Intrabody strategies for the treatment of human papillomavirus-associated disease
John Doorbar et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity
Maria Filippova et al.
JOURNAL OF VIROLOGY (2007)
Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells
Steven G. Milligan et al.
VIROLOGY (2007)
The natural history of cervical HPV infection: unresolved issues
Ciaran B. J. Woodman et al.
NATURE REVIEWS CANCER (2007)
The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16-or type 18-positive cervical cancer cell lines via translation reinitiation
S Tang et al.
JOURNAL OF VIROLOGY (2006)
Human papillomavirus vaccines
Margaret A. Stanley
REVIEWS IN MEDICAL VIROLOGY (2006)
Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation
A Carson et al.
JOURNAL OF VIROLOGY (2006)
Control of mRNA stability in eukaryotes
SF Newbury
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Development of a topical protein therapeutic for human papillomavirus and associated cancers
Katie L. Green et al.
BIODRUGS (2006)
Papillomavirus genome structure, expression, and post-transcriptional regulation
Zhi-Ming Zheng et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H
D Oberg et al.
JOURNAL OF VIROLOGY (2005)
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
J Soret et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate
NA Patterson et al.
JOURNAL OF VIROLOGY (2005)
A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein
XM Zhao et al.
JOURNAL OF VIROLOGY (2005)
Genetic analysis of the human papillomavirus type 31 differentiation-dependent late promoter
JM Bodily et al.
JOURNAL OF VIROLOGY (2005)
A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression
M Rush et al.
JOURNAL OF VIROLOGY (2005)
Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes
J You et al.
CELL (2004)
Advances in the development of therapeutic nucleic acids against cervical cancer
JA DiPaolo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Functional analysis of the human papillomavirus type 16 E1(boolean AND)E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization
Q Wang et al.
JOURNAL OF VIROLOGY (2004)
Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis
M Jiang et al.
OLIGONUCLEOTIDES (2004)
SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells
MG McPhillips et al.
JOURNAL OF VIROLOGY (2004)
A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA
JA Glahder et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers
K Middleton et al.
JOURNAL OF VIROLOGY (2003)
Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5′ splice sites that bind a U1 snRNP-like complex
SA Cumming et al.
JOURNAL OF VIROLOGY (2003)
Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses
S Shafti-Keramat et al.
JOURNAL OF VIROLOGY (2003)
Codon usage bias and A+T content variation in human papillomavirus genomes
KN Zhao et al.
VIRUS RESEARCH (2003)
Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription
MA Ozbun
JOURNAL OF VIROLOGY (2002)
Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region
L Wiklund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Assembly and translocation of papillomavirus capsid proteins
L Florin et al.
JOURNAL OF VIROLOGY (2002)
Human papillomavirus type 11 alters the transcription and expression of loricrin, the major cell envelope protein
E Lehr et al.
VIROLOGY (2002)
The human papillomavirus type 31 late 3′ untranslated region contains a complex bipartite negative regulatory element
SA Cumming et al.
JOURNAL OF VIROLOGY (2002)
Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression
LD Peña et al.
JOURNAL OF VIROLOGY (2001)
Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression
SS Terhune et al.
JOURNAL OF VIROLOGY (2001)
Heterogeneous nuclear ribonucleoprotein C binds exclusively to the functionally important UUUUU-motifs in the human papillomavirus type-1 AU-rich inhibitory element
M Sokolowski et al.
VIRUS RESEARCH (2001)
HuR and mRNA stability
CM Brennan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Association of the human papillomavirus type 11 E1-E4 protein with cornified cell envelopes derived from infected genital epithelium
JT Bryan et al.
VIROLOGY (2000)
Selection of alternative 5′ splice sites:: Role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1
IC Eperon et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels
MD Koffa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition
A Nishimura et al.
JOURNAL OF VIROLOGY (2000)
The E8-E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes
F Stubenrauch et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
